Literature DB >> 6702633

The femoral venous approach to endomyocardial biopsy: comparison with internal jugular and transarterial approaches.

J L Anderson, H W Marshall.   

Abstract

Endomyocardial biopsy is often used in the clinical evaluation of cardiac disease. Among 134 consecutive procedures (280 myocardial samples), 3 approaches were compared: right internal jugular (n = 69), femoral arterial (n = 30) and femoral venous (n = 35). The femoral venous approach is a new method with which a preformed guiding sheath is used to allow sampling of the apical right ventricular portion of the ventricular septum. Vascular access and myocardial sampling were successful in all femoral venous and left ventricular (LV) procedures; however, the internal jugular vein could not be located to allow biopsy in 12% of neck approaches (p less than 0.025). One case of pneumothorax occurred after an internal jugular approach. Chest pain occurred after 10% (3 patients) of the LV, 4% (3 patients) of internal jugular and 3% (1 patient) of femoral venous procedures. Hypotension associated with biopsy was noted after 3 internal jugular and 2 LV procedures. Pericardial effusion was observed in 3 patients after an LV procedure (p less than 0.01). In 1 of these patients tamponade developed. The femoral venous approach had the highest overall efficiency (successful biopsy, lack of adverse events, p less than 0.05). This approach may become the procedure of choice for routine endomyocardial biopsy because it allows reliable vascular access and myocardial sampling with a low incidence of adverse reactions.

Entities:  

Mesh:

Year:  1984        PMID: 6702633     DOI: 10.1016/0002-9149(84)90414-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  A new method for right ventricular endomyocardial biopsy via the femoral veins: a novel approach employing a right ventriculography catheter (Nishiya type).

Authors:  Y Nishiya; M Fujimura; M Toshima; H Noto; K Usuda; K Iuchi; T Ishikawa
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Three new applications of stent technology in a single patient.

Authors:  C J McMahon; H G El-Said; C E Mullins
Journal:  Tex Heart Inst J       Date:  2001

3.  Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy.

Authors:  Juyup Han; Yongwhi Park; Hyunsang Lee; Hyunjae Kang; Hyungseop Kim; Dong Heon Yang; Hun Sik Park; Yongkeun Cho; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

4.  Impact of vascular access site on procedural time of endomyocardial biopsy.

Authors:  Kentaro Mukai; Yusuke Nakano; Tomofumi Mizuno; Toru Niwa; Hirokazu Wakabayashi; Akihiro Suzuki; Atsushi Watanabe; Hirohiko Ando; Kenta Murotani; Katsuhisa Waseda; Tetsuya Amano
Journal:  Heart Vessels       Date:  2018-11-14       Impact factor: 2.037

5.  Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a german heart center.

Authors:  Thomas Strecker; Johannes Rösch; Michael Weyand; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 6.  Current status of endomyocardial biopsy.

Authors:  Aaron M From; Joseph J Maleszewski; Charanjit S Rihal
Journal:  Mayo Clin Proc       Date:  2011-11       Impact factor: 7.616

7.  Endomyocardial biopsy in infants and children: experience in 60 patients.

Authors:  A A Schmaltz; J Apitz; W Hort; B Maisch
Journal:  Pediatr Cardiol       Date:  1990-01       Impact factor: 1.655

8.  High-resolution respirometry in human endomyocardial biopsies shows reduced ventricular oxidative capacity related to heart failure.

Authors:  Daniel Scheiber; Tomas Jelenik; Elric Zweck; Patrick Horn; Heinz-Peter Schultheiss; Dirk Lassner; Udo Boeken; Diyar Saeed; Malte Kelm; Michael Roden; Ralf Westenfeld; Julia Szendroedi
Journal:  Exp Mol Med       Date:  2019-02-14       Impact factor: 8.718

9.  Insulin Resistance and Vulnerability to Cardiac Ischemia.

Authors:  Tomas Jelenik; Ulrich Flögel; Elisa Álvarez-Hernández; Daniel Scheiber; Elric Zweck; Zhaoping Ding; Maik Rothe; Lucia Mastrototaro; Vivien Kohlhaas; Jörg Kotzka; Birgit Knebel; Dirk Müller-Wieland; Sarah Moellendorf; Axel Gödecke; Malte Kelm; Ralf Westenfeld; Michael Roden; Julia Szendroedi
Journal:  Diabetes       Date:  2018-09-26       Impact factor: 9.461

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.